Rex Health Ventures is the corporate venture arm of UNC Healthcare and invests in cutting edge healthcare companies.
Business Model:
Revenue: $10M
Employees: 2-10
Address: 310 S Harrington St
City: Raleigh
State: NC
Zip: 27603
Country: US
Rex Health Ventures (RHV) supports the discovery and development of new treatments, tools, products and services that foster innovation and positively impacts the provision of healthcare. They invest in and partner with companies and entrepreneurs to help bring their products and services into the healthcare marketplace.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2020 | BioStable | Series C | - |
4/2019 | Bardy Diagnostics | Series B | 35.5M |
5/2016 | Arrivo BioVentures LLC | Investment Fund | 49M |
11/2021 | Pryon | Venture Round | 12M |
5/2018 | Emergo Therapeutics | Series A | 0 |
1/2023 | Censinet | Venture Round | 0 |
6/2016 | Kit Check | Series C | 0 |
9/2015 | Veran Medical Technologies | Venture Round | 0 |
7/2015 | Baebies | Venture Round | 0 |
11/2016 | Phononic | Series E | 0 |
12/2016 | Target PharmaSolutions | Series A | - |
6/2015 | Baebies | Series A | 13M |
11/2021 | Pryon | Funding Round | 0 |
10/2022 | Vergent Bioscience | Series B | 0 |
1/2019 | Phynd Technologies | Series B | 0 |
7/2012 | Aerial BioPharma | Venture Round | 500k |
6/2016 | Bluesight | Series C | 20.4M |
10/2018 | Gauss Surgical | Series C | 0 |
1/2015 | Bluesight | Series B | 12M |
11/2021 | Pryon | Funding Round | 0 |
2/2020 | BioStable | Series C | - |
4/2019 | Bardy Diagnostics | Series B | 0 |
1/2019 | Phynd Technologies | Series B | 0 |
10/2018 | Gauss Surgical | Series C | 0 |
5/2018 | Emergo Therapeutics | Series A | 0 |
12/2016 | Target PharmaSolutions | Series A | - |
11/2016 | Phononic | Series E | 0 |
6/2016 | Kit Check | Series C | 0 |
5/2016 | Arrivo BioVentures LLC | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|